Real world outcomes with alpelisib in metastatic hormone receptor-positive breast cancer patients: A single institution experience is a research paper published in Frontiers in Oncology (2022). On theSindex it has a DataRank of 0.442. It has been cited 18 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.442
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCATS NIH HHS
Grant: UL1 TR001412
NCATS NIH HHS
Grant: KL2 TR001413
National Institutes of Health
Grant: 5KL2TR001413-03
Buffalo Clinical and Translational Research Center
National Institutes of Health
Grant: 3UL1TR001412-08S3
Buffalo Clinical and Translational Research Center
Fields of Study
Keywords
Sustainable Development Goals